Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Janeiro 2024 - 6:30PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that it will participate in the 42nd Annual J.P.
Morgan Healthcare Conference taking place from January 8, 2024 to
January 11, 2024 in San Francisco, California.
The Company will present on Wednesday, January 10th at 8:15
a.m.(PT). A live webcast will be available on the Company’s website
at www.stevanatogroup.com under the "Investors" section. A replay
of the webcast will be available for approximately 90 days after
the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103393211/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Stevanato (NYSE:STVN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
